Nazem Atassi, MD

Dr. Atassi is an Associate Director of the NCRI at Massachusetts General Hospital, and an Associate Professor of Neurology at Harvard Medical School. He has hands-on experience leading a 10-site trial of tamozifen and creatine in ALS, and a 25-site International Methodology trial in ALS. He currently directs two unique clinical trials training fellowship programs with Biogen and Pfizer. 

Dr. Atassi is the CCC Liaison to the NeuroNEXT Education Committee.